Edition:
United States

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

13.28USD
3:55pm EDT
Change (% chg)

$-0.16 (-1.15%)
Prev Close
$13.44
Open
$13.42
Day's High
$13.60
Day's Low
$12.39
Volume
89,802
Avg. Vol
150,167
52-wk High
$31.69
52-wk Low
$12.39

Chart for

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

Beta: --
Market Cap(Mil.): $897.73
Shares Outstanding(Mil.): 56.18
Dividend: --
Yield (%): --

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -1.65 -- --
ROI: -65.34 13.18 12.83
ROE: -120.58 15.14 14.95

Earnings vs. Estimates